Ashish Kacholia’s Stock Pick Hits All-Time High on Strong Q2 Results
The company reported a consolidated net profit of Rs 37.33 crore, a major improvement from a loss of Rs 18.85 crore in the same period last year.
Ami Organics Limited’s shares surged by 5.43 per cent to close at Rs 1,913.30 today. During the intraday session, the stock reached an all-time high, jumping 9.26 per cent to Rs 1,989 on the NSE. This remarkable rise has added up to a massive 27.2 per cent gain over the last three trading sessions, propelled by the company’s strong Q2 financial results.
Ami Organics, a small-cap company specializing in specialty chemicals, showcased significant financial growth in Q2. The company reported a consolidated net profit of Rs 37.33 crore, a major improvement from a loss of Rs 18.85 crore in the same period last year. Revenue saw a robust 43 per cent rise to Rs 246.73 crore, up from Rs 172.36 crore, while total income climbed 46.8 per cent to Rs 255.17 crore, reflecting healthy growth across its core areas.
The company’s earnings before interest, tax, depreciation, and amortization (EBITDA) more than doubled, increasing to Rs 48.9 crore from Rs 24.8 crore a year earlier. The EBITDA margin also expanded by 540 basis points to 19.8 per cent from 14.4 per cent, highlighting improved efficiency and operational gains.
Veteran investor Ashish Kacholia, known for spotting high-growth potential stocks, owns a 1.84 per cent stake in Ami Organics, signaling his confidence in the company’s future.
DSIJ’s 'Tiny Treasure' service recommends researched small-cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.
About the Company
Ami Organics Limited is one of India’s leading specialty chemicals manufacturers, driven by research and development. The company produces advanced pharmaceutical intermediates, active pharmaceutical ingredients (API) for new chemical entities, as well as materials for agrochemicals and fine chemicals, serving a diverse range of industries.
Disclaimer: This article is for informational purposes only and not investment advice.